TI
Trexquant Investment Portfolio holdings
AUM
$8.86B
1-Year Return
23.46%
This Quarter Return
-2.57%
1 Year Return
+23.46%
3 Year Return
+83.97%
5 Year Return
+134.74%
10 Year Return
+204.61%
AUM
$3.99B
AUM Growth
+$171M
(+4.5%)
Cap. Flow
+$297M
Cap. Flow
% of AUM
7.44%
Top 10 Holdings %
Top 10 Hldgs %
8.83%
Holding
1,926
New
545
Increased
445
Reduced
417
Closed
518
Top Buys
| 1 |
Microsoft
MSFT
|
$41.1M |
| 2 |
Hershey
HSY
|
$33.7M |
| 3 |
Dell
DELL
|
$33.2M |
| 4 |
Procter & Gamble
PG
|
$31.7M |
| 5 |
Constellation Brands
STZ
|
$30.6M |
Top Sells
| 1 |
Humana
HUM
|
$33.3M |
| 2 |
MongoDB
MDB
|
$26.6M |
| 3 |
Carvana
CVNA
|
$24.8M |
| 4 |
McKesson
MCK
|
$23.4M |
| 5 |
Dollar Tree
DLTR
|
$21.3M |
Sector Composition
| 1 | Technology | 21.38% |
| 2 | Consumer Discretionary | 14.91% |
| 3 | Healthcare | 13.95% |
| 4 | Industrials | 10.91% |
| 5 | Financials | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
SPDR Dow Jones Industrial Average ETF Trust
DIA
$39.8B
| $3.47M | 0.09% |
+10,359
| New | +$3.47M |
|
327
Utilities Select Sector SPDR Fund
XLU
$20.7B
| $3.47M | 0.09% |
58,840
+16,754
| +40% | +$987K |
|
|
NARI
328
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.46M | 0.09% |
52,950
-9,284
| -15% | -$607K |
|
329
Braze
BRZE
$3.5B
| $3.45M | 0.09% |
73,877
-48,517
| -40% | -$2.27M |
|
330
Ameriprise Financial
AMP
$46.1B
| $3.44M | 0.09% |
10,424
+7,423
| +247% | +$2.45M |
|
331
Tower Semiconductor
TSEM
$7.07B
| $3.43M | 0.09% |
139,629
+103,777
| +289% | +$2.55M |
|
332
IonQ
IONQ
$12.4B
| $3.4M | 0.09% |
+228,606
| New | +$3.4M |
|
333
Coursera
COUR
$1.84B
| $3.4M | 0.09% |
181,939
+9,667
| +6% | +$181K |
|
334
Aflac
AFL
$57.2B
| $3.39M | 0.09% |
44,166
+23,433
| +113% | +$1.8M |
|
335
New York Times
NYT
$9.6B
| $3.38M | 0.08% |
81,979
+73,861
| +910% | +$3.04M |
|
336
Nu Holdings
NU
$71.2B
| $3.32M | 0.08% |
+457,543
| New | +$3.32M |
|
337
Inspire Medical Systems
INSP
$2.56B
| $3.3M | 0.08% |
16,652
+12,314
| +284% | +$2.44M |
|
|
CBAY
338
DELISTED
Cymabay Therapeutics
CBAY
| $3.28M | 0.08% |
219,755
+163,278
| +289% | +$2.43M |
|
339
Booz Allen Hamilton
BAH
$12.6B
| $3.27M | 0.08% |
+29,950
| New | +$3.27M |
|
340
TG Therapeutics
TGTX
$5.11B
| $3.26M | 0.08% |
390,507
+246,022
| +170% | +$2.06M |
|
341
Elanco Animal Health
ELAN
$9.16B
| $3.25M | 0.08% |
289,402
+127,394
| +79% | +$1.43M |
|
342
Chewy
CHWY
$17.5B
| $3.22M | 0.08% |
176,279
-99,611
| -36% | -$1.82M |
|
343
Xerox
XRX
$493M
| $3.19M | 0.08% |
203,175
+59,209
| +41% | +$929K |
|
|
AZEK
344
DELISTED
The AZEK Co
AZEK
| $3.19M | 0.08% |
107,136
+1,321
| +1% | +$39.3K |
|
|
IMGN
345
DELISTED
Immunogen Inc
IMGN
| $3.19M | 0.08% |
200,746
+123,379
| +159% | +$1.96M |
|
346
Consolidated Edison
ED
$35.4B
| $3.18M | 0.08% |
37,190
-6,162
| -14% | -$527K |
|
347
Cincinnati Financial
CINF
$24B
| $3.17M | 0.08% |
31,006
-50,302
| -62% | -$5.15M |
|
348
United Therapeutics
UTHR
$18.1B
| $3.17M | 0.08% |
+14,036
| New | +$3.17M |
|
349
UiPath
PATH
$6.15B
| $3.14M | 0.08% |
183,678
-196,022
| -52% | -$3.35M |
|
350
Garmin
GRMN
$45.7B
| $3.14M | 0.08% |
29,857
-50,433
| -63% | -$5.31M |
|